secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2021-09-14T23:59:59+00:00
Accession:  0001654954-21-010086
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q3 revenue falls 20.5% YoY; net income boosted by $1.96M PPP forgiveness
--------------------------------------------------------------------------------

- Revenue for Q3 $4.99M, down 20.5% YoY from $6.28M.
- Net income $2.28M includes $1.96M PPP loan forgiveness; prior year $0.69M.
- Nine-month revenue $14.5M vs $16.5M, down 12.2% YoY.
- Company focused on M&A strategy and geographic expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495421010086/0001654954-21-010086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495421010086/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-010086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer